EP3577129A1 — Methods for treating fungal infections
Assigned to Cidara Therapeutics Inc · Expires 2019-12-11 · 6y expired
What this patent protects
The invention relates to methods of treating dermatophytosis (e.g., onychomycosis) in a subject by subcutaneously administering to the subject CD101, in salt or neutral form. In some embodiments, CD101 in salt or neutral form is administered in combination with at least one antif…
USPTO Abstract
The invention relates to methods of treating dermatophytosis (e.g., onychomycosis) in a subject by subcutaneously administering to the subject CD101, in salt or neutral form. In some embodiments, CD101 in salt or neutral form is administered in combination with at least one antifungal agent.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.